<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id><journal-id journal-id-type="pmc">eid</journal-id><journal-title>Emerging Infectious Diseases</journal-title><issn pub-type="ppub">1080-6040</issn><issn pub-type="epub">1080-6059</issn><publisher><publisher-name>Centers for Disease Control</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">9866750</article-id><article-id pub-id-type="pmc">2640237</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Differentiating human from animal isolates of Cryptosporidium parvum.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sulaiman</surname><given-names>I. M.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Xiao</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>C.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Escalante</surname><given-names>L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Moore</surname><given-names>A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Beard</surname><given-names>C. B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Arrowood</surname><given-names>M. J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Lal</surname><given-names>A. A.</given-names></name></contrib></contrib-group><aff>Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</aff><pub-date pub-type="ppub"><season>Oct-Dec</season><year>1998</year></pub-date><volume>4</volume><issue>4</issue><fpage>681</fpage><lpage>685</lpage><abstract><p>We analyzed 92 Cryptosporidium parvum isolates from humans and animals by a polymerase chain reaction/restriction fragment length polymorphism method based on the thrombospondin-related anonymous protein 2 gene sequence. Used as a molecular marker, this method can differentiate between the two genotypes of C. parvum and elucidate the transmission of infection to humans.</p></abstract></article-meta></front></article>